Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012 (2012), Article ID 716564, 6 pages
http://dx.doi.org/10.1155/2012/716564
Review Article

Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment

1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, 1670 University Boulvard, VH 566A, P.O. Box 202, Birmingham, AL 35294-0009, USA
2Veteran's Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
3Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA

Received 15 August 2011; Accepted 19 September 2011

Academic Editor: Douglas R. Hurst

Copyright © 2012 Debika Bhattacharya and Nabiha Yusuf. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Breast Cancer: Facts and Figures, 2011.
  2. S. González-Reyes, L. Marín, L. González et al., “Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis,” BMC Cancer, vol. 10, article 665, 2010. View at Publisher · View at Google Scholar · View at PubMed
  3. H. Yu, M. Kortylewski, and D. Pardoll, “Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment,” Nature Reviews Immunology, vol. 7, no. 1, pp. 41–51, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
  5. D. G. DeNardo, M. Johansson, and L. M. Coussens, “Immune cells as mediators of solid tumor metastasis,” Cancer and Metastasis Reviews, vol. 27, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. Matzinger, “Tolerance, danger, and the extended family,” Annual Review of Immunology, vol. 12, pp. 991–1045, 1994. View at Google Scholar · View at Scopus
  7. B. Beutler, “Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease,” Immunological Reviews, vol. 220, no. 1, pp. 113–128, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. E. Bianchi, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Gordon, “Pattern recognition receptors: doubling up for the innate immune response,” Cell, vol. 111, no. 7, pp. 927–930, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Medzhitov and C. A. Janeway, “Decoding the patterns of self and nonself by the innate immune system,” Science, vol. 296, no. 5566, pp. 298–300, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. G. P. Dunn, L. J. Old, and R. D. Schreiber, “The immunobiology of cancer immunosurveillance and immunoediting,” Immunity, vol. 21, no. 2, pp. 137–148, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. E. M. Creagh and L. A. J. O'Neill, “TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity,” Trends in Immunology, vol. 27, no. 8, pp. 352–357, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. R. F. Wang, Y. Miyahara, and H. Y. Wang, “Toll-like receptors and immune regulation: implications for cancer therapy,” Oncogene, vol. 27, no. 2, pp. 181–189, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Iwasaki and R. Medzhitov, “Toll-like receptor control of the adaptive immune responses,” Nature Immunology, vol. 5, no. 10, pp. 987–995, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. B. Huang, J. Zhao, H. Li et al., “Toll-like receptors on tumor cells facilitate evasion of immune surveillance,” Cancer Research, vol. 65, no. 12, pp. 5009–5014, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. B. Huang, J. Zhao, S. Shen et al., “Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling,” Cancer Research, vol. 67, no. 9, pp. 4346–4352, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. G. Kelly, A. B. Alvero, R. Chen et al., “TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer,” Cancer Research, vol. 66, no. 7, pp. 3859–3868, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. A. O. Aliprantis, R. B. Yang, M. R. Mark et al., “Cell activation and apoptosis by bacterial lipoproteins through Toll- like receptor-2,” Science, vol. 285, no. 5428, pp. 736–739, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, “Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3,” Nature, vol. 413, no. 6857, pp. 732–738, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. F. Hayashi, K. D. Smith, A. Ozinsky et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5,” Nature, vol. 410, no. 6832, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. F. Heil, H. Hemmi, H. Hochrein et al., “Species-specific recognition of single-stranded RNA via till-like receptor 7 and 8,” Science, vol. 303, no. 5663, pp. 1526–1529, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. A. M. Piccinini and K. S. Midwood, “DAMPening inflammation by modulating TLR signalling,” Mediators of Inflammation, vol. 2010, Article ID 672395, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. K. Takeda and S. Akira, “TLR signaling pathways,” Seminars in Immunology, vol. 16, no. 1, pp. 3–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. L. A. J. O'Neill, “How Toll-like receptors signal: what we know and what we don't know,” Current Opinion in Immunology, vol. 18, no. 1, pp. 3–9, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. T. Kawai and S. Akira, “Pathogen recognition with Toll-like receptors,” Current Opinion in Immunology, vol. 17, no. 4, pp. 338–344, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. L. O. González, S. González-Reyes, L. Marín et al., “Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas,” Histopathology, vol. 57, no. 6, pp. 862–876, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. R. Giavazzi, A. Garofalo, M. R. Bani et al., “Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice,” Cancer Research, vol. 50, no. 15, pp. 4771–4775, 1990. View at Google Scholar · View at Scopus
  33. J. L. Luo, W. Tan, J. M. Ricono et al., “Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin,” Nature, vol. 446, no. 7136, pp. 690–694, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. A. Mantovani, P. Romero, A. K. Palucka, and F. M. Marincola, “Tumour immunity: effector response to tumour and role of the microenvironment,” The Lancet, vol. 371, no. 9614, pp. 771–783, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. A. Sica and V. Bronte, “Altered macrophage differentiation and immune dysfunction in tumor development,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1155–1166, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. J. B. Wyckoff, Y. Wang, E. Y. Lin et al., “Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors,” Cancer Research, vol. 67, no. 6, pp. 2649–2656, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. A. Mantovani, T. Schioppa, C. Porta, P. Allavena, and A. Sica, “Role of tumor-associated macrophages in tumor progression and invasion,” Cancer and Metastasis Reviews, vol. 25, no. 3, pp. 315–322, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. Yang, J. Huang, X. Ren et al., “Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis,” Cancer Cell, vol. 13, no. 1, pp. 23–35, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. Y. C. Lu, I. Kim, E. Lye et al., “Differential role for c-Rel and C/EBPβ/δ in TLR-mediated induction of proinflammatory cytokines,” Journal of Immunology, vol. 182, no. 11, pp. 7212–7221, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, “The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance,” Immunological Reviews, vol. 222, no. 1, pp. 155–161, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. H. Yang, H. Zhou, P. Feng et al., “Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 92, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. M. A. Merrell, J. M. Ilvesaro, N. Lehtonen et al., “Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity,” Molecular Cancer Research, vol. 4, no. 7, pp. 437–447, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. Sandholm, J. H. Kauppila, C. Pressey et al., “Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells,” Breast Cancer Research and Treatment. In press.
  44. B. Salaun, L. Zitvogel, C. Asselin-Paturel et al., “TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer,” Cancer Research, vol. 71, no. 5, pp. 1607–1614, 2011. View at Google Scholar
  45. Z. Cai, A. Sanchez, Z. Shi, T. Zhang, M. Liu, and D. Zhang, “Activation of toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth,” Cancer Research, vol. 71, no. 7, pp. 2466–2475, 2011. View at Publisher · View at Google Scholar · View at PubMed
  46. L. Das Roy, L. B. Pathangey, T. L. Tinder, J. L. Schettini, H. E. Gruber, and P. Mukherjee, “Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis,” Breast Cancer Research, vol. 11, no. 4, article R56, 2009. View at Publisher · View at Google Scholar · View at PubMed
  47. X. Su, J. Ye, E. C. Hsueh, Y. Zhang, D. F. Hoft, and G. Peng, “Tumor microenvironments direct the recruitment and expansion of human Th17 cells,” Journal of Immunology, vol. 184, no. 3, pp. 1630–1641, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. E. J. Hennessy, A. E. Parker, and L. A. J. O'Neill, “Targeting Toll-like receptors: emerging therapeutics?” Nature Reviews Drug Discovery, vol. 9, no. 4, pp. 293–307, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle, “Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer,” Pharmacological Reviews, vol. 61, no. 2, pp. 177–197, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus